Product Information
XHANCE 93 MCG EXHALATION DELIVERY NASAL SPRAY is a brand product labeled by OptiNose US, Inc., priced at $40.8371 per ML under NDC 71143037501. Its NADAC has been published 416 times since Oct 17, 2018.
FDA first approved this application on Sep 18, 2017.
The High Outlier badge above means this manufacturer's average price in the fluticasone propionate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
93 ug/1
Manufacturer
OptiNose US, Inc.NDC
71143037501
Classification
Brand
Dosage Form
SPRAY, METERED
Route
NASAL
Effective Date
9/23/2026
Active Ingredients
FLUTICASONE PROPIONATEApproval Type
New Drug (NDA)
FDA Application
NDA209022FDA Approved
9/18/2017
On Market Since
10/3/2017
Pharmacological Classes
Price Statistics
The NADAC for XHANCE 93 MCG EXHALATION DELIVERY NASAL SPRAY has been published 416 times since Oct 17, 2018, and over the history we have for it it has risen 52.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $40.8371 per ML |
|---|---|
| All-time high | $40.9013 (May 13, 2026) |
| All-time low | $26.7752 (Oct 17, 2018) |
| 52-week high | $40.9013 |
| 52-week low | $39.3270 |
| Median price | $34.0555 |
| Average price | $34.5688 |
| Largest weekly change | +5.5% (Jan 13, 2021) |
| Weeks tracked | 416 |
| Tracking since | Oct 17, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the fluticasone propionate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
OptiNose US, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
fluticasone propionate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of XHANCE 93 MCG EXHALATION DELIVERY NASAL SPRAY?
The current National Average Drug Acquisition Cost (NADAC) for XHANCE 93 MCG EXHALATION DELIVERY NASAL SPRAY, manufactured by OptiNose US, Inc., is $40.8371 per ML (NDC 71143037501), effective Sep 30, 2026.
How has the price of XHANCE 93 MCG EXHALATION DELIVERY NASAL SPRAY changed over time?
Over the history we have for it, the NADAC for XHANCE 93 MCG EXHALATION DELIVERY NASAL SPRAY has risen 52.5%. It has been tracked across 416 weekly CMS publications since Oct 17, 2018.
What are the highest and lowest recorded NADAC prices for XHANCE 93 MCG EXHALATION DELIVERY NASAL SPRAY?
Since Oct 17, 2018, the NADAC for XHANCE 93 MCG EXHALATION DELIVERY NASAL SPRAY has ranged from a low of $26.7752 (Oct 17, 2018) to a high of $40.9013 (May 13, 2026), with a median of $34.0555 per ML.
Are there cheaper alternatives to XHANCE 93 MCG EXHALATION DELIVERY NASAL SPRAY?
No other NADAC-published product currently shares the active ingredient and strength of XHANCE 93 MCG EXHALATION DELIVERY NASAL SPRAY in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures XHANCE 93 MCG EXHALATION DELIVERY NASAL SPRAY?
XHANCE 93 MCG EXHALATION DELIVERY NASAL SPRAY (NDC 71143037501) is labeled by OptiNose US, Inc., and CMS classifies it as a brand product.